Group items tagged

Genetic Testing of 18 Hereditary Cancer This test can provide risk assessment in high-risk groups with a family history by detecting gene mutations in the entire coding region and splice region of 64 genes associated with 18 hereditary tumors at one time.

Embryology 2019 will offer an exciting & wide range of scientific program designed to captivate high profile scientific International on topics of importance related to the Embryology. This conference is the perfect occasion for the International experts to share their valuable expertise on recent research advancements in embryology and human genetics. This conference will provide the perfect stage for all the embryologists, geneticists, endocrinologists, gynaecologists, reproductive biologi...

The Disease Susceptibility Genetic Test-Breast Cancer IVD Medical Device | Capitalbio

The Disease Susceptibility Genetic Test-Cancer Screening Package (29 Items) IVD Medical Device | Capitalbio

The Disease Susceptibility Genetic Test-Cardiovascular Disease (14 Items) IVD Medical Device | Capitalbio

Epilepsy-related Gene Detection The Epilepsy-related gene testing of CapitalBio Technology is based on BES4000 semi-conductor sequencing platform, using target region capture and NGS technology together to detect the genes related epilepsy.

Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic] This test detects somatic and germline SNV, InDel and CNV mutations in the BRCA1 and BRCA2 genes, covering the entire coding region of the BRCA1/2 gene and both flanking intron regions, provide information to guide PARP inhibitor therapy in breast & ovarian cancer.

Folic Acid Utilization Ability Genetic Detection Folic acid is mainly involved in nucleic acid, protein synthesis and DNA methylation in the human body, and is an essential micronutrient for the human body. The human body cannot synthesize folic acid on its own and must obtain it from food. But some people develop folic acid deficiencies even when they maintain a normal intake of folic acid.

Genetic Testing for Blood Cancer This test can detect SNV, Indel, and FLT3-ITD information of 232 genes associated with blood cancers, covers all types of leukemia - AML/ALL/CML/CLL/MDS/MPN and various lymphomas.

Individualized Medication Guidance for Breast Cancer This test detects 348 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.

CapitalBio Technology Co., Ltd. (abbreviated "CapitalBio") is the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips.

A variety of products and services have been exported to more than 30 countries and regions in North America, Europe, Asia, and so on. The biochip-related products developed have twice won the National Technology Invention Award's second prize.

CapitalBio Technology Co., Ltd. (abbreviated "CapitalBio") is the industrialization platform of the CapitalBio Corporation and the Beijing National Engineering Research Center for Biochips.

With 20+ years' experience, national scientific research platforms and bioinformatics expertise, we are always dedicated to assisting researchers advance the life sciences. We have professional scientists to provide services for the whole process, from free consulting and experiment design to data interpretation.

Capitalbio: Biochips Based In Vitro Diagnostics (IVD) Solutions for Genetic Research

According to research reports, individuals with inherited cancer genes have a higher risk of cancer than ordinary people. About 7% of breast cancer and 1%-15% of ovarian cancer are caused by BRCA1/BRCA2 gene mutations. In families with a high incidence of breast and ovarian cancer, 80% of patients have mutations in the BRCA1/BRCA2 gene, and this gene is inherited in an autosomal dominant manner in the population. This test detects the entire coding region of BRCA1/BRCA2 genes, and 20bp intron regions upstream and downstream of the coding region, in addition to known mutation hotspot genes, unknown mutations can be detected.

Lactococcus lactis has been used extensively in the production of buttermilk and cheese. It was also the first genetically modified organism (GMO) to be used alive as a therapeutic treatment for human disease.